Cafepharma Today

Memorial Day Weekend 2025
We wish all our US visitors a safe and enjoyable holiday weekend. We remember those who have given their lives to defend and protect our country.

CP Today will resume on Tuesday, May 27

*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

How Gilead Sciences Became A Big Name In Biotech
Investopedia
Tuesday, August 12, 2014 - 8:31am
tags:
Gilead Sciences
Biotechs That Might Benefit From Ebola
Yahoo/Benzinga
Tuesday, August 12, 2014 - 8:29am
tags:
ebola virus, Tekmira Pharmaceuticals, Sarepta Therapeutics, Biocryst, NanoViricides
Inversion Talk Helps AstraZeneca Stay Grounded
WSJ Online
Tuesday, August 12, 2014 - 8:08am
tags:
AstraZeneca, tax inversions, M&A
Exact Sciences Wins U.S. Approval for Colon Cancer Test
Bloomberg
Monday, August 11, 2014 - 6:20pm
tags:
diagnostics, colon cancer, EXACT Sciences, Cologuard
PharmAthene to Share Up to $500 Million in Smallpox Drug Profits
Bloomberg
Monday, August 11, 2014 - 6:19pm
tags:
smallpox, PharmAthene, SIGA technologies, Arestvyr
Intercept Pharma Shares Higher on Positive Fatty Liver Drug Data
TheStreet.com
Monday, August 11, 2014 - 6:11pm
tags:
Intercept Pharma, OCA, nonalcoholic steatohepatitis
How Will GlaxoSmithKilne (GSK) Stock Respond To New Drug Bribery Allegations In Syria?
TheStreet.com
Monday, August 11, 2014 - 5:22pm
tags:
GSK, bribery, Syria
Forward Pharma sets sights on Biogen with a $200M IPO
Fierce Biotech
Monday, August 11, 2014 - 11:55am
tags:
Forward Pharma, Biogen Idec, IPOs, FP187, MS, multiple sclerosis
Medivation Jumps on Q2 Earnings Beat, Outlook Encourages
Yahoo/Zacks.com
Monday, August 11, 2014 - 11:53am
tags:
earnings, Medivation
Alnylam's Q2 Loss Wider-than-Expected, Pipeline in Focus
Yahoo/Zacks.com
Monday, August 11, 2014 - 11:53am
tags:
earnings, Alnylam
Osiris Falls despite Narrower Q2 Loss and Higher Revenues
Yahoo/Zacks.com
Monday, August 11, 2014 - 11:52am
tags:
Osiris, earnings
New use for Bayer's Eylea in EU gives it more market power against Novartis' Lucentis
Fierce Pharma
Monday, August 11, 2014 - 11:51am
tags:
Europe, Novartis, Lucentis, Eylea, Bayer
FDA Accepts First-Ever Biosimilar Application for Monoclonal Antibody
RAPS.org
Monday, August 11, 2014 - 11:13am
tags:
Remsima, Remicade, monoclonal antibodies, FDA, Celltrion, biosimilars
Big Investors ask Drug Maker Boards not to Denigrate Biosimilars
WSJ Online
Monday, August 11, 2014 - 10:59am
tags:
biosimilars
Ebola Drug Maker Tekmira Shares Are Exploding Higher Again
Yahoo/Business Insider
Monday, August 11, 2014 - 10:54am
tags:
ebola virus, TKM-EBOLA, Tekmira Pharmaceuticals
J&J's diabetes combo wins FDA nod in a fast-crowding space
Fierce Biotech
Monday, August 11, 2014 - 10:53am
tags:
JNJ, diabetes, FDA, Invokamet
Med tech M&A gets much, much bigger during the first half
Fierce Medical Devices
Monday, August 11, 2014 - 8:52am
tags:
M&A, devices, Medtronic, Covidien, Zimmer, Biomet, Smith & Nephew, ArthroCare, Carlyle, Ortho Clinical Diagnostics, Sauflon, Cooper Companies
Sanofi fills some big shoes in $925M Afrezza pact with MannKind
Fierce Biotech
Monday, August 11, 2014 - 8:48am
tags:
Sanofi, MannKind, insulin, Afrezza, inhaled insulin, diabetes
Clinical trial to start soon on GSK Ebola vaccine
Reuters
Monday, August 11, 2014 - 8:44am
tags:
GSK, ebola virus, vaccines, Okairos
Most popular news headlines for Friday, August 8 2014
CP Wire
Monday, August 11, 2014 - 8:41am
tags:
Allergan, China, diabetes, ebola virus, FDA, GSK, Lipitor, M&A, Pfizer, Tekmira Pharmaceuticals, TKM-EBOLA, Valeant Pharmaceuticals

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.